🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 7 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/03/2022 24,35 25,52 24,09 25,41 +5,83% 5,89% 749.900
08/03/2022 23,99 24,32 22,93 24,01 +0,67% 5,79% 993.300
07/03/2022 24,70 24,98 23,19 23,85 -1,89% 7,25% 590.500
04/03/2022 25,68 26,43 24,20 24,31 -7,39% 8,68% 396.100
03/03/2022 26,66 27,15 25,87 26,25 -1,24% 4,80% 922.800
02/03/2022 25,95 27,52 25,03 26,58 +1,26% 9,61% 755.800
01/03/2022 24,29 27,97 24,29 26,25 +8,11% 15,15% 829.400
28/02/2022 24,12 25,28 23,93 24,28 -0,86% 5,60% 362.200
25/02/2022 24,34 25,08 23,91 24,49 +0,99% 4,83% 539.500
24/02/2022 22,77 24,34 22,56 24,25 +3,90% 7,80% 2.113.100
23/02/2022 24,40 24,56 23,21 23,34 -4,34% 5,53% 575.600
22/02/2022 24,33 25,27 24,33 24,40 -1,81% 3,86% 662.700
18/02/2022 25,50 26,04 24,57 24,85 -2,43% 5,76% 468.300
17/02/2022 26,35 27,37 25,15 25,47 -4,61% 8,43% 670.400
16/02/2022 28,49 28,92 26,56 26,70 -7,07% 8,28% 500.000
15/02/2022 28,36 28,88 26,97 28,73 +5,01% 6,73% 2.838.400
14/02/2022 27,28 28,58 27,16 27,36 -1,76% 5,21% 1.346.300
11/02/2022 28,00 29,13 27,78 27,85 +1,46% 4,82% 597.800
10/02/2022 28,16 28,52 26,91 27,45 -3,38% 5,72% 841.800
09/02/2022 28,26 29,25 27,87 28,41 +1,76% 4,87% 695.800
08/02/2022 28,20 28,37 27,10 27,92 -0,29% 4,50% 503.900
07/02/2022 28,20 29,10 27,75 28,00 -0,85% 4,79% 447.100
04/02/2022 29,05 29,45 28,07 28,24 -2,45% 4,75% 598.100
03/02/2022 29,00 29,62 28,29 28,95 -1,56% 4,59% 346.100
02/02/2022 30,30 30,42 29,31 29,41 -2,78% 3,66% 622.400
01/02/2022 29,89 30,40 28,48 30,25 +3,28% 6,42% 368.900
31/01/2022 28,27 29,75 28,27 29,29 +4,05% 5,24% 538.000
28/01/2022 26,49 28,15 25,96 28,15 +6,71% 8,27% 704.900
27/01/2022 29,18 29,65 26,27 26,38 -7,18% 11,58% 603.800
26/01/2022 29,28 30,34 28,00 28,42 -1,32% 7,99% 635.000